Halozyme Therapeutics (HALO) Other Non-Current Liabilities (2009 - 2026)
Halozyme Therapeutics' Other Non-Current Liabilities came in at $102.68 million for Q2 2026, up 32.0% from $77.77 million a year earlier but down 3.5% from the prior quarter.
Powered by 
Analysis
Halozyme Therapeutics (HALO) Other Non-Current Liabilities (2009 - 2026) Analysis & Trends
At the end of FY2025, Halozyme Therapeutics' Other Non-Current Liabilities was $113.86 million, up 107.9% from FY2024.
- Other Non-Current Liabilities has increased in each of the last three years, with a five-year compound annual growth rate of 101.1% (FY2020 to FY2025).
- Going back by year, Other Non-Current Liabilities was $54.76 million in FY2024 (+45.2%), $37.72 million in FY2023 (+15.4%), $32.69 million in FY2022 and $544,000 in FY2021 (-84.3%).
- The five-year range for quarterly Other Non-Current Liabilities is $171,000 (Q1 2022) to $130 million (Q2 2022).
- Year-over-year, Other Non-Current Liabilities has increased for eight consecutive quarters, with growth averaging 78.7% over the last eight quarters.
- The fastest year-over-year change in Other Non-Current Liabilities over five years came in Q2 2025 (growth of 154.9%), and the weakest in Q1 2022 (a decline of 93.9%).
- Business Quant data shows HALO's Other Non-Current Liabilities at $106.45 million (Q1 2026), $113.86 million (Q4 2025) and $71.8 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Halozyme Therapeutics | 11.73 Bn | 9.97 Bn | 410.50 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 101.47 Mn |
| Jun 30, 2026 | 102.68 Mn |
| Mar 31, 2026 | 106.45 Mn |
| Dec 31, 2025 | 113.86 Mn |
| Sep 30, 2025 | 71.80 Mn |
| Jun 30, 2025 | 77.77 Mn |
| Mar 31, 2025 | 56.44 Mn |
| Dec 31, 2024 | 54.76 Mn |
| Sep 30, 2024 | 40.41 Mn |
| Jun 30, 2024 | 30.51 Mn |
| Mar 31, 2024 | 31.20 Mn |
| Dec 31, 2023 | 37.72 Mn |
| Sep 30, 2023 | 28.42 Mn |
| Jun 30, 2023 | 44.76 Mn |
| Mar 31, 2023 | 45.05 Mn |
| Dec 31, 2022 | 48.16 Mn |
| Sep 30, 2022 | 135.19 Mn |
| Jun 30, 2022 | 135.55 Mn |
| Mar 31, 2022 | 171,000.00 |
| Dec 31, 2021 | 544,000.00 |
API Access
Halozyme Therapeutics Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=HALO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "HALO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=HALO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();